37901-90-9 Usage
Uses
Used in Chemical Synthesis:
2-Nitro-3-Amino-4-Methylbenzoic Acid is used as an intermediate in the production of other chemicals in various industries. Its unique functional groups make it a valuable building block for the synthesis of a wide range of compounds, including pharmaceuticals, dyes, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Nitro-3-Amino-4-Methylbenzoic Acid is used as a key intermediate for the synthesis of various drug molecules. Its presence in the molecular structure can contribute to the development of new therapeutic agents with potential applications in treating different medical conditions.
Used in Dye Manufacturing:
2-Nitro-3-Amino-4-Methylbenzoic Acid is also used in the dye manufacturing industry as a precursor for the production of various types of dyes. Its chemical properties allow for the creation of dyes with specific color characteristics and stability, which are essential for various applications, such as textiles, plastics, and printing inks.
Used in Research and Development:
In the field of research and development, 2-Nitro-3-Amino-4-Methylbenzoic Acid is used as a model compound for studying the properties and reactivity of aromatic benzoic acids. This helps scientists and researchers to better understand the behavior of these compounds and develop new methods for their synthesis and application.
Check Digit Verification of cas no
The CAS Registry Mumber 37901-90-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,7,9,0 and 1 respectively; the second part has 2 digits, 9 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 37901-90:
(7*3)+(6*7)+(5*9)+(4*0)+(3*1)+(2*9)+(1*0)=129
129 % 10 = 9
So 37901-90-9 is a valid CAS Registry Number.
InChI:InChI=1/C8H8N2O4/c1-4-2-3-5(8(11)12)7(6(4)9)10(13)14/h2-3H,9H2,1H3,(H,11,12)
37901-90-9Relevant academic research and scientific papers
COVALENT INHIBITORS OF KRAS
-
, (2018/12/13)
Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, stereoisomer, isotopic form or prodrug thereof, wherein R1, R2a,
CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
-
, (2015/03/13)
Chemical entities that are kinase inhibitors, pharmaceutical compositions and methods of treatment of cancer are described.
NITROGEN-CONTAINING BICYCLIC HETEROARYL COMPOUNDS AND METHODS OF USE
-
Page/Page column 71, (2008/06/13)
The present invention comprises a new class of compounds capable of modulating Raf kinase and, accordingly, useful for treatment of Raf kinase mediated diseases, including melanomas, tumors and other cancer-related conditions. The compounds have Formula (I) wherein R1 is Formula (II), (III) or (IV) and A1, A2, A3, A4, X, Z, Z', R1, R2, R3, R4, R5 and R6 are defined herein. The invention further comprises pharmaceutical compositions, methods for treatment of Raf kinase mediated diseases, and intermediates and processes useful for the preparation of compounds of the invention.
Methods of making 6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile and its preferred salt form
-
Page 23, (2010/02/08)
6-[(4,5-Dihydro-1H-imidazol-2-yl)amino-]-7-methyl-1H-benzimidazole-4-carbonitrile substantially free of 2,3,7-triamino-4,6-dimethyl-1,9-phenazinedicarbonitrile, and the anhydrous monoacetate salt thereof, are useful in the treatment of alpha-2 mediated di
